KR101499735B1 - 교반을 이용한 유연성 용기 내의 헌혈자의 혈액, 혈장 또는적혈구 농축액 안의 병원체의 불활성화 방법 - Google Patents

교반을 이용한 유연성 용기 내의 헌혈자의 혈액, 혈장 또는적혈구 농축액 안의 병원체의 불활성화 방법 Download PDF

Info

Publication number
KR101499735B1
KR101499735B1 KR1020087017172A KR20087017172A KR101499735B1 KR 101499735 B1 KR101499735 B1 KR 101499735B1 KR 1020087017172 A KR1020087017172 A KR 1020087017172A KR 20087017172 A KR20087017172 A KR 20087017172A KR 101499735 B1 KR101499735 B1 KR 101499735B1
Authority
KR
South Korea
Prior art keywords
bag
exposure
blood
plasma
agitation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020087017172A
Other languages
English (en)
Korean (ko)
Other versions
KR20080081038A (ko
Inventor
하랄드 모르
Original Assignee
블루트슈펜데딘스트 데르 란데쓰베르밴데 데스 도이첸 로텐 크로이쩨스 니다사흐센, 사흐센-안할트, 튜링엔, 올덴부르그 운드 브레멘 게게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 블루트슈펜데딘스트 데르 란데쓰베르밴데 데스 도이첸 로텐 크로이쩨스 니다사흐센, 사흐센-안할트, 튜링엔, 올덴부르그 운드 브레멘 게게엠베하 filed Critical 블루트슈펜데딘스트 데르 란데쓰베르밴데 데스 도이첸 로텐 크로이쩨스 니다사흐센, 사흐센-안할트, 튜링엔, 올덴부르그 운드 브레멘 게게엠베하
Publication of KR20080081038A publication Critical patent/KR20080081038A/ko
Application granted granted Critical
Publication of KR101499735B1 publication Critical patent/KR101499735B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet [UV] radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
KR1020087017172A 2005-12-23 2006-12-21 교반을 이용한 유연성 용기 내의 헌혈자의 혈액, 혈장 또는적혈구 농축액 안의 병원체의 불활성화 방법 Active KR101499735B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005062634A DE102005062634A1 (de) 2005-12-23 2005-12-23 Verfahren zur Inaktivierung von Pathogenen in Spenderblut, Blutplasma oder Erythrozytenkonzentraten in flexiblen Behältnissen unter Bewegung
DE102005062634.3 2005-12-23
PCT/DE2006/002307 WO2007076832A1 (de) 2005-12-23 2006-12-21 Verfahren zur inaktivierung von pathogenen in spenderblut, blutplasma oder erythrozytenkonzentraten in flexiblen behältnissen unter bewegung

Publications (2)

Publication Number Publication Date
KR20080081038A KR20080081038A (ko) 2008-09-05
KR101499735B1 true KR101499735B1 (ko) 2015-03-06

Family

ID=38043033

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087017172A Active KR101499735B1 (ko) 2005-12-23 2006-12-21 교반을 이용한 유연성 용기 내의 헌혈자의 혈액, 혈장 또는적혈구 농축액 안의 병원체의 불활성화 방법

Country Status (16)

Country Link
US (2) US8164073B2 (https=)
EP (2) EP1962905B1 (https=)
JP (1) JP5232008B2 (https=)
KR (1) KR101499735B1 (https=)
CN (1) CN101340930B (https=)
AT (2) ATE514432T1 (https=)
AU (1) AU2006332291B2 (https=)
CA (1) CA2632558C (https=)
DE (2) DE102005062634A1 (https=)
DK (2) DK1962905T3 (https=)
ES (2) ES2341368T3 (https=)
PL (2) PL2198886T3 (https=)
PT (2) PT1962905E (https=)
RU (1) RU2466742C2 (https=)
SI (2) SI2198886T1 (https=)
WO (1) WO2007076832A1 (https=)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220007638A1 (en) * 2019-06-11 2022-01-13 Paragonix Technologies, Inc. Organ transport container with antiviral therapy
US12245586B2 (en) 2011-03-15 2025-03-11 Paragonix Technologies, Inc. System for hypothermic transport of samples
US12310357B2 (en) 2020-01-31 2025-05-27 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
US12357533B2 (en) 2023-08-25 2025-07-15 Paragonix Technologies, Inc. Systems and methods for maintaining organ pressure
USD1087382S1 (en) 2025-01-30 2025-08-05 Paragonix Technologies, Inc. Device for transporting a biological sample
US12410408B2 (en) 2024-02-02 2025-09-09 Paragonix Technologies, Inc. Method for hypothermic transport of biological samples
US12564187B2 (en) 2017-06-07 2026-03-03 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
US12610943B2 (en) 2025-06-24 2026-04-28 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005062410A1 (de) 2005-12-23 2007-08-09 Forschungsgemeinschaft Der Drk-Blutspendedienste E.V. Verfahren zur Bestrahlung von Thrombozytenkonzentraten in flexiblen Behältnissen mit ultraviolettem Licht
DE102005062634A1 (de) 2005-12-23 2007-06-28 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH Verfahren zur Inaktivierung von Pathogenen in Spenderblut, Blutplasma oder Erythrozytenkonzentraten in flexiblen Behältnissen unter Bewegung
EP1902740A1 (en) 2006-09-19 2008-03-26 Maco Pharma S.A. Blood bag system and process for the inactivation of pathogens in platelet concentrates by use of the blood bag system
EP2008669A1 (en) 2007-06-22 2008-12-31 Maco Pharma S.A. Irradiation apparatus for inactivating pathogens and/or leukocytes in a biological fluid and process
EP2459248B1 (en) * 2009-06-02 2019-05-22 biolitec Unternehmensbeteiligungs II AG A novel method for microbial depletion in human blood and blood products using antimicrobial photodynamic therapy
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
US8883409B1 (en) * 2013-12-08 2014-11-11 Hemalux LLC Method of reducing pathogens in whole blood by illuminating with ultraviolet light under low oxygen conditions
CN107833751A (zh) * 2017-10-27 2018-03-23 吉林化工学院 一种复合膜电极制备方法及光电性质检测方法
US12558463B2 (en) 2019-03-11 2026-02-24 ABC Med Tech Corp. Portable centrifuge device and method of use
US11964092B2 (en) 2019-03-11 2024-04-23 ABC Med Tech Corp. Portable centrifuge and method of use
EP4034303B1 (en) * 2019-09-24 2024-03-20 ABC Med Tech Corp. Centrifuge device and method of use
US20210338860A1 (en) 2020-05-01 2021-11-04 Uv Innovators, Llc Ultraviolet (uv) light emission device employing visible light for operation guidance, and related methods of use, particularly suited for decontamination
FR3117872A1 (fr) * 2020-12-21 2022-06-24 Maco Pharma Procédé et système pour produire des cellules mononucléées apoptotiques
JP7776724B2 (ja) 2021-04-27 2025-11-27 日亜化学工業株式会社 カルシウムチャネル及び／又はカルシウムポンプの発現を誘導する方法及び培養装置
DE102021119408A1 (de) * 2021-07-27 2023-02-02 Blutspendedienst der Landesverbände des DRK in Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen g.G.m.b.H. Additivlösung für Erythrozytenkonzentrate
CN115350296A (zh) * 2022-08-30 2022-11-18 南京双威生物医学科技有限公司 基于核黄素光化学法的血液病原体灭活处理系统

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004081692A (ja) * 2002-08-28 2004-03-18 Terumo Corp 光照射装置および光照射方法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469227A (en) 1983-08-17 1984-09-04 Clifford Faust Package for cryogenically frozen liquids
US4586928A (en) 1984-10-09 1986-05-06 Miles Laboratories, Inc. Pivoting frangible valve for plastic bags
US4952812A (en) 1986-08-26 1990-08-28 Baxter International Inc. Irradiation of blood products
US4878891A (en) 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
GB8807380D0 (en) * 1988-03-29 1988-05-05 Gunn A Blood processing apparatus
US5661126A (en) * 1989-01-19 1997-08-26 The General Hospital Corporation Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression
US4952818A (en) 1989-05-17 1990-08-28 International Business Machines Corporation Transmission line driver circuits
JP3051997B2 (ja) * 1990-12-20 2000-06-12 バクスター、インターナショナル、インコーポレイテッド 液体中の汚染物を根絶するシステム及び方法
JPH05131018A (ja) 1991-11-11 1993-05-28 Terumo Corp バツグ連結体およびその製造方法
US6420570B1 (en) * 1993-06-28 2002-07-16 Cerus Corporation Psoralen compounds
US5625079A (en) 1993-06-28 1997-04-29 Cerus Corporation Synthesizing psoralen compounds useful as intermediates
JP3677287B2 (ja) 1993-11-10 2005-07-27 セラス コーポレーション 光活性化のための装置および方法
DK0840624T3 (da) 1995-07-14 2007-11-05 Caf Dcf Cvba Scrl Apparat til inaktivering af viruskontaminanter i blodprodukter
DE29801590U1 (de) 1998-01-30 1998-04-16 Maco Pharma Int Gmbh Blutbeutelsystem zur Virusinaktivierung von Blut, Blutkomponenten und Plasma
DE19831768A1 (de) * 1998-07-15 2000-02-17 Paa Lab Gmbh Vorrichtung zur Bestrahlung einer Flüssigkeit
EP1002512A3 (en) 1998-11-19 2001-01-24 Bracco International B.V. Flexible container for the containment and delivery of fluids
US7068361B2 (en) 1999-06-03 2006-06-27 Baxter International Apparatus, systems and methods for processing and treating a biological fluid with light
US7445756B2 (en) 1999-06-03 2008-11-04 Fenwal, Inc. Fluid processing sets and organizers for the same
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
US6596230B1 (en) * 2000-01-28 2003-07-22 Baxter International Inc. Device and method for pathogen inactivation of therapeutic fluids with sterilizing radiation
US6576201B1 (en) * 2000-01-28 2003-06-10 Baxter International Inc. Device and method for pathogen inactivation of therapeutic fluids with sterilizing radiation
WO2002026270A2 (en) 2000-09-27 2002-04-04 Gambro, Inc. Inactivation of contaminants using photosensitizers and pulsed light
US20020138066A1 (en) 2001-03-23 2002-09-26 Gambro, Inc. Multiple compartment bag with openable closure assembly
WO2002092806A1 (en) * 2001-05-15 2002-11-21 V.I. Technologies, Inc. Apparatus for the inactivation of pathogens in protein-containingfluids
US20030064001A1 (en) 2001-05-17 2003-04-03 Fries William M. System for the decontamination of fluid products using light
US20030228564A1 (en) 2001-05-30 2003-12-11 Edrich Richard Alan Nitric oxide in a pathogen inactivation process
WO2003026724A1 (en) 2001-09-27 2003-04-03 Gambro, Inc. Radio frequency or electromagnetic information systems and methods for use in extracorporeal blood processing
DE10152159A1 (de) 2001-10-25 2003-05-15 Aventis Behring Gmbh Verfahren zur proteinschonenden Reinigung von kontaminierten biologischen Flüssigkeiten
WO2003063915A1 (en) 2002-02-01 2003-08-07 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
MXPA04010027A (es) 2002-04-12 2005-07-01 Throwleigh Technologies L L C Metodos y aparatos para descontaminar fluidos.
EP1501555B1 (en) 2002-04-26 2007-02-21 Gambro, Inc., Apparatus for irradiating and mixing fluids in containers
US7207964B2 (en) 2003-03-17 2007-04-24 Hemavation, Llc Apparatus and method for down-regulating immune system mediators in blood
US20080177217A1 (en) * 2004-05-14 2008-07-24 Hans-Dietrich Polaschegg Taurolidine Formulations and Delivery: Therapeutic Treatments and Antimicrobial Protection Against Bacterial Biofilm Formation
US8296071B2 (en) * 2004-03-15 2012-10-23 Terumo Bct Biotechnologies, Llc Methods for uniformly treating biological samples with electromagnetic radiation
FR2887335B1 (fr) 2005-06-21 2007-08-10 Maco Pharma Sa Procede pour la determination d'une contamination pathogene dans un fluide contenant des plaquettes sanguines
DE102005062634A1 (de) 2005-12-23 2007-06-28 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH Verfahren zur Inaktivierung von Pathogenen in Spenderblut, Blutplasma oder Erythrozytenkonzentraten in flexiblen Behältnissen unter Bewegung
DE102005062410A1 (de) 2005-12-23 2007-08-09 Forschungsgemeinschaft Der Drk-Blutspendedienste E.V. Verfahren zur Bestrahlung von Thrombozytenkonzentraten in flexiblen Behältnissen mit ultraviolettem Licht
EP1902740A1 (en) 2006-09-19 2008-03-26 Maco Pharma S.A. Blood bag system and process for the inactivation of pathogens in platelet concentrates by use of the blood bag system
EP2008669A1 (en) 2007-06-22 2008-12-31 Maco Pharma S.A. Irradiation apparatus for inactivating pathogens and/or leukocytes in a biological fluid and process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004081692A (ja) * 2002-08-28 2004-03-18 Terumo Corp 光照射装置および光照射方法

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12543729B2 (en) 2011-03-15 2026-02-10 Paragonix Technologies, Inc. System for hypothermic transport of samples
US12245586B2 (en) 2011-03-15 2025-03-11 Paragonix Technologies, Inc. System for hypothermic transport of samples
US12279610B2 (en) 2011-03-15 2025-04-22 Paragonix Technonogies, Inc. System for hypothermic transport of samples
US12342810B2 (en) 2011-03-15 2025-07-01 Paragonix Technologies, Inc. System for hypothermic transport of samples
US12369576B2 (en) 2011-03-15 2025-07-29 Paragonix Technologies, Inc. System for hypothermic transport of samples
US12557806B2 (en) 2011-03-15 2026-02-24 Paragonix Technologies, Inc. System for hypothermic transport of samples
US12564187B2 (en) 2017-06-07 2026-03-03 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
US12245585B2 (en) * 2019-06-11 2025-03-11 Paragonix Technonogies, Inc. Organ transport container with antiviral therapy
US20220007638A1 (en) * 2019-06-11 2022-01-13 Paragonix Technologies, Inc. Organ transport container with antiviral therapy
US12310357B2 (en) 2020-01-31 2025-05-27 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
US12357533B2 (en) 2023-08-25 2025-07-15 Paragonix Technologies, Inc. Systems and methods for maintaining organ pressure
US12485064B2 (en) 2023-08-25 2025-12-02 Paragonix Technologies, Inc. Systems and methods for measuring oxygen concentration for lung preservation
US12410408B2 (en) 2024-02-02 2025-09-09 Paragonix Technologies, Inc. Method for hypothermic transport of biological samples
USD1087382S1 (en) 2025-01-30 2025-08-05 Paragonix Technologies, Inc. Device for transporting a biological sample
US12610943B2 (en) 2025-06-24 2026-04-28 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation

Also Published As

Publication number Publication date
JP2009520703A (ja) 2009-05-28
EP1962905B1 (de) 2010-02-17
CA2632558A1 (en) 2007-07-12
US20070164233A1 (en) 2007-07-19
ES2369059T3 (es) 2011-11-24
US8525128B2 (en) 2013-09-03
DE102005062634A1 (de) 2007-06-28
PL1962905T3 (pl) 2010-08-31
ES2341368T3 (es) 2010-06-18
RU2008129480A (ru) 2010-01-27
AU2006332291A1 (en) 2007-07-12
DK2198886T3 (da) 2011-10-10
RU2466742C2 (ru) 2012-11-20
JP5232008B2 (ja) 2013-07-10
EP2198886B1 (de) 2011-06-29
WO2007076832A1 (de) 2007-07-12
EP1962905A1 (de) 2008-09-03
KR20080081038A (ko) 2008-09-05
SI2198886T1 (sl) 2011-11-30
EP2198886A1 (de) 2010-06-23
HK1121406A1 (zh) 2009-04-24
DE502006006204D1 (de) 2010-04-01
HK1121407A1 (en) 2009-04-24
HK1144249A1 (en) 2011-02-11
CN101340930B (zh) 2012-09-05
PT1962905E (pt) 2010-05-14
PL2198886T3 (pl) 2012-01-31
AU2006332291B2 (en) 2012-02-23
CN101340930A (zh) 2009-01-07
ATE457739T1 (de) 2010-03-15
SI1962905T1 (sl) 2010-06-30
DK1962905T3 (da) 2010-06-07
CA2632558C (en) 2013-06-11
DE102005062634A9 (de) 2007-10-11
US20120228517A1 (en) 2012-09-13
PT2198886E (pt) 2011-09-28
ATE514432T1 (de) 2011-07-15
US8164073B2 (en) 2012-04-24

Similar Documents

Publication Publication Date Title
KR101499735B1 (ko) 교반을 이용한 유연성 용기 내의 헌혈자의 혈액, 혈장 또는적혈구 농축액 안의 병원체의 불활성화 방법
AU2001236787B2 (en) Protecting molecules in biologically derived compositions while treating with broad-spectrum pulsed light
JP6283162B2 (ja) ヒト血液及び血液製剤における微生物枯渇のための新たな方法
US8173066B2 (en) Method for irradiating thrombocyte concentrates in flexible containers with ultra-violet light
JPH08501807A (ja) 体液中のウイルス汚染物を不活性化するための装置および方法
HK1121407B (en) Method for the inactivation of pathogens in donor blood, blood plasma or erythrocyte concentrations in flexible containers under agitation
HK1121406B (en) Method for the inactivation of pathogens in donor blood, blood plasma or erythrocyte concentrations in flexible containers using agitation
HK1144249B (en) Method for inactivating pathogens in donor blood, blood plasma or erythrocyte concentrates in flexible containers in motion
HK1121974A (en) Method for irradiating thrombocyte concentrates in flexible containers with ultra-violet light
HK1121975B (en) Method for irradiating thrombocyte concentrates in flexible containers with ultra-violet light

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20180221

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20190221

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 12